Purnima Singh

8PUBLICATIONS
42CO-AUTHORS
Predictive and prognostic markersMolecular targetsHaematological tumoursEpigenetics (incl. genome methylation and epigenomics)Exercise physiology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Aug 19, 2025
Germline Pathogenic/Likely Pathogenic Mutations and Subsequent Neoplasms Among Childhood Cancer Survivors: A Report From the Children's Oncology Group ALTE03N1 Study.

Liting Zhou, Purnima Singh, David Crossman

|Mar 28, 2025
DNA Damage Response and Repair Genes and Anthracycline-Induced Cardiomyopathy in Childhood Cancer Survivors: A Report From the Children's Oncology Group and the Childhood Cancer Survivor Study.

Xuexia Wang, Purnima Singh, Romina B Cejas

|Aug 02, 2024
Sex-Based Differences in Risk of Therapy-Related Myeloid Neoplasms.

Melissa A Richard, Chengcheng Yan, Yanjun Chen

|Apr 18, 2024
Clonal Hematopoiesis and Therapy-Related Myeloid Neoplasms After Autologous Transplant for Hodgkin Lymphoma.

Chengcheng Yan, Melissa A Richard, Christopher J Gibson

|Sep 26, 2023
Altered Peripheral Blood Gene Expression in Childhood Cancer Survivors With Anthracycline-Induced Cardiomyopathy - A COG-ALTE03N1 Report.

Purnima Singh, Disheet A Shah, Mariam Jouni

|Nov 18, 2021
EHMT2 suppresses the variation of transcriptional switches in the mouse embryo.

Tie-Bo Zeng, Nicholas Pierce, Ji Liao

Pageof 2

Frequent Collaborators

6 joint publications

Smita Bhatia

5 joint publications

Saro H Armenian

4 joint publications

David K Crossman

3 joint publications

Joseph P Neglia